- Home
- ZVIA vs FBIO Comparison
ZVIA vs FBIO Comparison
Compare ZVIA & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- FBIO
- Stock Information
- Founded
- ZVIA 2007
- FBIO 2006
- Country
- ZVIA United States
- FBIO United States
- Employees
- ZVIA N/A
- FBIO N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ZVIA Consumer Staples
- FBIO Health Care
- Exchange
- ZVIA Nasdaq
- FBIO Nasdaq
- Market Cap
- ZVIA 65.0M
- FBIO 48.2M
- IPO Year
- ZVIA 2021
- FBIO N/A
- Fundamental
- Price
- ZVIA $1.11
- FBIO $1.81
- Analyst Decision
- ZVIA Hold
- FBIO Strong Buy
- Analyst Count
- ZVIA 4
- FBIO 4
- Target Price
- ZVIA $1.56
- FBIO $16.33
- AVG Volume (30 Days)
- ZVIA 110.7K
- FBIO 629.5K
- Earning Date
- ZVIA 11-05-2024
- FBIO 11-12-2024
- Dividend Yield
- ZVIA N/A
- FBIO N/A
- EPS Growth
- ZVIA N/A
- FBIO N/A
- EPS
- ZVIA N/A
- FBIO N/A
- Revenue
- ZVIA $160,108,000.00
- FBIO $82,624,000.00
- Revenue This Year
- ZVIA N/A
- FBIO N/A
- Revenue Next Year
- ZVIA $10.43
- FBIO $81.63
- P/E Ratio
- ZVIA N/A
- FBIO N/A
- Revenue Growth
- ZVIA N/A
- FBIO 31.68
- 52 Week Low
- ZVIA $0.62
- FBIO $1.24
- 52 Week High
- ZVIA $2.42
- FBIO $4.43
- Technical
- Relative Strength Index (RSI)
- ZVIA 52.18
- FBIO 61.24
- Support Level
- ZVIA $1.05
- FBIO $1.50
- Resistance Level
- ZVIA $1.17
- FBIO $1.65
- Average True Range (ATR)
- ZVIA 0.06
- FBIO 0.09
- MACD
- ZVIA -0.00
- FBIO 0.05
- Stochastic Oscillator
- ZVIA 42.50
- FBIO 91.49
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.